The Psychedelic Podcast cover image

Sam Mandel - 30,000 Infusions Later: Clinical Insights from a Ketamine Pioneer

The Psychedelic Podcast

00:00

Navigating the Future of Psychedelic Therapy Post-FDA Rejection

This chapter discusses the FDA's recent rejection of MDMA-assisted therapy and its impact on the landscape of psychedelic treatments, particularly ketamine therapy. The conversation highlights the necessity of a multidisciplinary approach in mental health care while advocating for patient safety and the incorporation of new therapies as they emerge.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app